Jacobsen, I.C. et al. 2025. Outcomes for patients with high-risk ER-positive, HER2-negative early-stage breast cancer: a Danish real-world study. Acta Oncologica. 64, (Nov. 2025), 1531–1539. DOI:https://doi.org/10.2340/1651-226X.2025.44003.